Literature DB >> 17106921

Crohn's disease: innate immunodeficiency?

Jesus-K Yamamoto-Furusho1, Joshua-R Korzenik.   

Abstract

In the past, Crohn's disease (CD) has been understood primarily as an immunologic disorder characterized by an abnormal T-cell response. Recent in vitro and in vivo data suggests that CD may instead be precipitated by innate immune dysfunction resulting from a combination of genetic and environmental factors. Some reports have demonstrated a defective immune response in a variety of other cellular components, including neutrophils, monocytes and dendritic cells. Recent studies of granulocyte-macrophage colony-stimulating factor (GM-CSF) in CD, aiming to stimulate the innate immune system with the conception that an innate immune defect underlies the development of the disease, have been demonstrated a clinical benefit and reinforce this evolving understanding of the disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17106921      PMCID: PMC4087427          DOI: 10.3748/wjg.v12.i42.6751

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  47 in total

1.  Crohn's disease associated with autoimmune neutropenia.

Authors:  C Stevens; M A Peppercorn; R J Grand
Journal:  J Clin Gastroenterol       Date:  1991-06       Impact factor: 3.062

Review 2.  Emerging applications of recombinant human granulocyte-macrophage colony-stimulating factor.

Authors:  J O Armitage
Journal:  Blood       Date:  1998-12-15       Impact factor: 22.113

Review 3.  Complement and function of neutrophils in chronic inflammatory bowel disease.

Authors:  J Elmgreen
Journal:  Dan Med Bull       Date:  1986-10

4.  Impaired granulopoiesis, myelodysplasia, and early lethality in CCAAT/enhancer binding protein epsilon-deficient mice.

Authors:  R Yamanaka; C Barlow; J Lekstrom-Himes; L H Castilla; P P Liu; M Eckhaus; T Decker; A Wynshaw-Boris; K G Xanthopoulos
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-25       Impact factor: 11.205

5.  Leucocyte adhesion deficiency presenting as a chronic ileocolitis.

Authors:  I D D'Agata; K Paradis; Z Chad; Y Bonny; E Seidman
Journal:  Gut       Date:  1996-10       Impact factor: 23.059

6.  Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils.

Authors:  K Takeda; B E Clausen; T Kaisho; T Tsujimura; N Terada; I Förster; S Akira
Journal:  Immunity       Date:  1999-01       Impact factor: 31.745

7.  Chediak-Higashi syndrome with intestinal complication. Report of a case.

Authors:  E Ishii; T Matui; M Iida; T Inamitu; K Ueda
Journal:  J Clin Gastroenterol       Date:  1987-10       Impact factor: 3.062

8.  Chronic inflammatory bowel disease in glycogen storage disease type 1B.

Authors:  I R Sanderson; W M Bisset; P J Milla; J V Leonard
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982

9.  Superoxide production by Crohn's disease neutrophils.

Authors:  F T Curran; R N Allan; M R Keighley
Journal:  Gut       Date:  1991-04       Impact factor: 23.059

10.  Crohn's disease associated with cyclic neutropenia.

Authors:  R D Lamport; S Katz; D Eskreis
Journal:  Am J Gastroenterol       Date:  1992-11       Impact factor: 10.864

View more
  10 in total

1.  Effect of fuzzy partitioning in Crohn's disease classification: a neuro-fuzzy-based approach.

Authors:  Sk Saddam Ahmed; Nilanjan Dey; Amira S Ashour; Dimitra Sifaki-Pistolla; Dana Bălas-Timar; Valentina E Balas; João Manuel R S Tavares
Journal:  Med Biol Eng Comput       Date:  2016-04-22       Impact factor: 2.602

Review 2.  The IL-1 family: regulators of immunity.

Authors:  John E Sims; Dirk E Smith
Journal:  Nat Rev Immunol       Date:  2010-01-18       Impact factor: 53.106

Review 3.  Growth factors as treatment for inflammatory bowel disease: a concise review of the evidence toward their potential clinical utility.

Authors:  Josué Barahona-Garrido; Jorge Hernández-Calleros; Ignacio García-Juárez; Jesús K Yamamoto-Furusho
Journal:  Saudi J Gastroenterol       Date:  2009 Jul-Sep       Impact factor: 2.485

4.  [41-year old patient with obscure diarrhea].

Authors:  T Brünnler; F Bataille; F Hofstädter; G Birkenfeld; J Schölmerich
Journal:  Internist (Berl)       Date:  2009-09       Impact factor: 0.743

5.  Heterozygous nucleotide-binding oligomerization domain-2 mutations affect monocyte maturation in Crohn's disease.

Authors:  Marilena Granzotto; Elisa Fabbro; Massimo Maschio; Stefano Martelossi; Sara Quaglia; Alberto Tommasini; Gianni Presani; Alessandro Ventura
Journal:  World J Gastroenterol       Date:  2007-12-14       Impact factor: 5.742

Review 6.  Innovative therapeutics for inflammatory bowel disease.

Authors:  Jesus-K Yamamoto-Furusho
Journal:  World J Gastroenterol       Date:  2007-04-07       Impact factor: 5.742

7.  Serum copper, ceruloplasmin and 24-h urine copper evaluations in celiac patients.

Authors:  Ali Tüzün Ince; Hüseyin Kayadibi; Aliye Soylu; Oya Ovunç; Mustafa Gültepe; Ahmet Burak Toros; Bülent Yaşar; Tulin Kendir; Evren Abut
Journal:  Dig Dis Sci       Date:  2008-06       Impact factor: 3.199

Review 8.  Pivotal roles of GM-CSF in autoimmunity and inflammation.

Authors:  Aoi Shiomi; Takashi Usui
Journal:  Mediators Inflamm       Date:  2015-03-08       Impact factor: 4.711

9.  Deletion of SOCS2 Reduces Post-Colitis Fibrosis via Alteration of the TGFβ Pathway.

Authors:  Amna Al-Araimi; Amira Al Kharusi; Asma Bani Oraba; Matar M Al-Maney; Shadia Al Sinawi; Ibrahim Al-Haddabi; Fahad Zadjali
Journal:  Int J Mol Sci       Date:  2020-04-27       Impact factor: 5.923

10.  New treatment options in the management of IBD - focus on colony stimulating factors.

Authors:  Josué Barahona-Garrido; Jesús K Yamamoto-Furusho
Journal:  Biologics       Date:  2008-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.